Analysis of HIV‐1 mutation patterns in patients failing antiretroviral therapy

The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV‐1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations...

詳細記述

保存先:
書誌詳細
出版年:J Clin Lab Anal
主要な著者: Quiros‐Roldan, Eugenia, Signorini, Simona, Castelli, Francesco, Torti, Carlo, Patroni, Andrea, Airoldi, Monica, Carosi, Giampiero
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Inc. 2001
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807694/
https://ncbi.nlm.nih.gov/pubmed/11170234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1098-2825(2001)15:1<43::AID-JCLA9>3.0.CO;2-I
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料